Literature DB >> 24206536

Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.

G K Reynolds1, D P Lewis, A M Richardson, B A Lidbury.   

Abstract

OBJECTIVE: Patients with chronic fatigue syndrome (CFS) are frequently diagnosed with comorbid postural orthostatic tachycardia syndrome (POTS), suggesting a shared pathogenesis. The aim of this study was to examine the relationship between demographic characteristics, autonomic functioning and fatigue levels amongst CFS patients with and without comorbid POTS. DESIGN AND
SETTING: All patients presenting to the CFS Discovery Clinic between 2009 and 2012 completed a 20-min standing task as part of their initial assessment. Heart rate and pulse pressure were recorded at baseline, at 2-min intervals poststanding, at the end of the task and following a recovery period. Average heart rate and pulse pressure variability were calculated from this data. Age, gender, length of illness and self-reported fatigue scores were also recorded. POTS patients were diagnosed by an orthostatic increase in heart rate >30 beats per min, concomitant symptoms of orthostatic intolerance and no orthostatic hypotension. Differences in autonomic functioning between POTS and CFS patients were compared using independent samples t-tests, whilst logistic and linear regressions were performed to examine the contribution of autonomic functioning to task completion and perceived fatigue, respectively.
RESULTS: Comorbidity of CFS and POTS (CFS-POTS) was observed in 11% (33/306) of patients. CFS-POTS patients were significantly younger (P < 0.001), had a shorter length of illness (P = 0.034), experienced greater task difficulty (P = 0.002) and were able to stand for significantly shorter periods compared to the CFS-only patients (P < 0.001). CFS-POTS patients experienced significantly lower baseline diastolic blood pressure (P = 0.002), significantly higher heart rate and lower pulse pressures at each standing measurement. Early heart rate changes (P = 0.002) and overall heart rate change (P < 0.001) were significant predictors of completion status, whereas heart rate variability (P < 0.001) and female gender (P < 0.001) were significant predictors of increased perceived task difficulty.
CONCLUSIONS: Haemodynamic and demographic differences between CFS-POTS and CFS-only patients suggest that the former group reflects a distinct subgroup of the CFS population. The findings highlight the utility of screening younger patients with fatigue for POTS, and identified heart rate variability as an important marker of fatigue for CFS patients in general.
© 2013 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  autonomic function; chronic fatigue syndrome; fatigue syndromes; postural orthostatic tachycardia syndrome; standing test

Mesh:

Year:  2013        PMID: 24206536     DOI: 10.1111/joim.12161

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  26 in total

Review 1.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 2.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

3.  Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Authors:  Jangsup Moon; Do-Yong Kim; Woo-Jin Lee; Han Sang Lee; Jung-Ah Lim; Tae-Joon Kim; Jin-Sun Jun; Byeongsu Park; Jung-Ick Byun; Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

4.  Associations Between Autonomic and Orthostatic Self-report and Physician Ratings of Orthostatic Intolerance in Youth.

Authors:  Katlin R Schultz; Ben Z Katz; Neil R Bockian; Leonard A Jason
Journal:  Clin Ther       Date:  2019-03-12       Impact factor: 3.393

5.  Autonomic Testing in Women with Chronic Pelvic Pain.

Authors:  Gisela Chelimsky; Pippa Simpson; Noel McCabe; Liyun Zhang; Thomas Chelimsky
Journal:  J Urol       Date:  2016-03-26       Impact factor: 7.450

6.  Chronic fatigue syndrome in the emergency department.

Authors:  Christian R Timbol; James N Baraniuk
Journal:  Open Access Emerg Med       Date:  2019-01-11

7.  Replacing Myalgic Encephalomyelitis and Chronic Fatigue Syndrome with Systemic Exercise Intolerance Disease Is Not the Way forward.

Authors:  Frank N M Twisk
Journal:  Diagnostics (Basel)       Date:  2016-02-05

Review 8.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome.

Authors:  Jangsup Moon; Do-Yong Kim; Jung-Ick Byun; Jun-Sang Sunwoo; Jung-Ah Lim; Tae-Joon Kim; Jung-Won Shin; Woo-Jin Lee; Han Sang Lee; Jin-Sun Jun; Kyung-Il Park; Keun-Hwa Jung; Soon-Tae Lee; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Health Qual Life Outcomes       Date:  2016-10-12       Impact factor: 3.186

10.  Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.

Authors:  Brett A Lidbury; Badia Kita; Donald P Lewis; Susan Hayward; Helen Ludlow; Mark P Hedger; David M de Kretser
Journal:  J Transl Med       Date:  2017-03-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.